Remote work is no longer a pandemic experiment. It is now a permanent part of how the global job market operates. There are now three times more remote jobs available in 2026 than back in 2020 in the ...

Trillion Parameter run achieved with DeepSeek R1 671B model on 36 Nvidia H100 GPUs We are pleased to offer a Trillion ...

Ads to be tested on free and Go plan users in the US in coming weeks Ads won't affect ChatGPT answers or share user data with marketers Analysts warn ads could drive ChatGPT users to competitors Jan ...

Versant, Comcast’s media and entertainment business spin-off, has announced the completion of its acquisition of Free TV Networks (FTN), a US provider of free over-the-air digital broadcast networks ...

This article features deals sourced directly by Gizmodo and produced independently of the editorial team. We may earn a commission when you buy through links on the site. Reading time 7 minutes Names ...

Video editing Mac users can efficiently produce professional-looking content on a MacBook Air thanks to iMovie's intuitive interface and the hardware acceleration of M-series chips. Beginners benefit ...

Surveying the state of America’s artificial intelligence landscape earlier this year, Misha Laskin was concerned. Laskin, a theoretical physicist and machine learning engineer who helped create some ...

What’s happened? Google has unlocked some of the advanced Gemini features in Google Vids that were previously limited to paid subscribers for anyone with a Gmail account. Why is this important? By ...

And Canva really, really wants you to know that it’s completely free. And Canva really, really wants you to know that it’s completely free. is a news writer focused on creative industries, computing ...

Ivonescimab plus chemotherapy improved PFS by 40% compared to Tevimbra in advanced squamous NSCLC, with a median PFS of 11.14 months versus 6.9 months. The study demonstrated consistent PFS benefits ...

Patients with previously untreated, locally advanced, unresectable or metastatic triple-negative breast cancer who are not candidates for inhibitors of programmed cell death protein 1 (PD-1) or ...